Suchen
IRIDEX Corp
IRIXZur Watchlist hinzufügen
1.130USD
-0.040-3.42%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
19.66MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über IRIDEX Corp Unternehmen
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
IRIDEX Corp Informationen
BörsenkürzelIRIX
Name des UnternehmensIRIDEX Corp
IPO-datumFeb 16, 1996
CEOMercer (Patrick)
Anzahl der mitarbeiter93
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 16
Addresse1212 Terra Bella Ave
StadtMOUNTAIN VIEW
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94043
Telefon16509404700
Websitehttps://www.iridex.com/
BörsenkürzelIRIX
IPO-datumFeb 16, 1996
CEOMercer (Patrick)
Führungskräfte von IRIDEX Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. William M. (Will) Moore, Jr.
Mr. William M. (Will) Moore, Jr.
Independent Director
Independent Director
402.00K
--
Mr. Patrick Mercer
Mr. Patrick Mercer
President, Chief Executive Officer, Chief Operating Officer, Director
President, Chief Executive Officer, Chief Operating Officer, Director
162.07K
-2.46%
Mr. Romeo R. Dizon
Mr. Romeo R. Dizon
Chief Financial Officer
Chief Financial Officer
110.78K
+6.57%
Ms. Beverly A. Huss
Ms. Beverly A. Huss
Independent Director
Independent Director
92.64K
--
Mr. Scott A. Shuda, J.D.
Mr. Scott A. Shuda, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Yu Hao (Nick) Chen
Mr. Yu Hao (Nick) Chen
Independent Director
Independent Director
--
--
Mr. Bassem Bouhabib
Mr. Bassem Bouhabib
Vice President - International Sales
Vice President - International Sales
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. William M. (Will) Moore, Jr.
Mr. William M. (Will) Moore, Jr.
Independent Director
Independent Director
402.00K
--
Mr. Patrick Mercer
Mr. Patrick Mercer
President, Chief Executive Officer, Chief Operating Officer, Director
President, Chief Executive Officer, Chief Operating Officer, Director
162.07K
-2.46%
Mr. Romeo R. Dizon
Mr. Romeo R. Dizon
Chief Financial Officer
Chief Financial Officer
110.78K
+6.57%
Ms. Beverly A. Huss
Ms. Beverly A. Huss
Independent Director
Independent Director
92.64K
--
Mr. Scott A. Shuda, J.D.
Mr. Scott A. Shuda, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Yu Hao (Nick) Chen
Mr. Yu Hao (Nick) Chen
Independent Director
Independent Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von IRIDEX Corp?
Die fünf größten Anteilseigner von IRIDEX Corp sind: Mr. William M. (Will) Moore, Jr.
Wie viele Institutionen halten Anteile an IRIDEX Corp (IRIX)?
Mit Stand vom 2026Q1 halten 52 Institutionen Anteile an IRIDEX Corp, mit einem Gesamtmarktwert von etwa 3.69M, was 21.29% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 278304.00 gestiegen.
Was ist die größte Einnahmequelle von IRIDEX Corp?
Am 2026Q1 erzielte das Geschäft mit Retina für IRIDEX Corp den höchsten Umsatz in Höhe von 6.70M, was 53.65% des Gesamtumsatzes entspricht.